EN
登录

心理健康治疗服务提供商Radial获5000万美元融资,以扩大先进脑医学的可及性

Radial Launches with $50 Million to Expand Access to Advanced Brain Medicine

vcaonline 等信源发布 2025-12-09 23:27

可切换为仅中文


Radial Launches with $50 Million to Expand Access to Advanced Brain Medicine

Radial公司获得5000万美元融资,用于扩大先进脑医学的获取途径。

NEW YORK, December 9, 2025-- Radial today announced the company has raised $50 million in venture funding to create access to the world's most advanced mental health treatments. The company is backed by General Catalyst, who led the Series A, and additional investors Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, and Diede van Lamoen..

纽约,2025年12月9日——Radial公司今天宣布,已筹集到5000万美元的风险投资,用于提供世界上最先进的心理健康治疗。该公司得到了General Catalyst的支持,后者领投了A轮融资,其他投资者包括Solari Capital、JSL Health Capital、Founder Collective、BoxGroup、Scrub Capital和Diede van Lamoen。

New brain medicines – treatments like neuromodulation (e.g. accelerated transcranial magnetic stimulation, (TMS)) and rapid-acting medications (e.g. Spravato) that directly heal the brain – are achieving far better outcomes for patients with mental health conditions. These treatments work in days to weeks, with some studies showing remission rates as high as 78%.

新型大脑药物——如神经调节(例如加速经颅磁刺激 (TMS))和快速作用药物(例如 Spravato)等直接修复大脑的治疗方法——正在为心理健康状况患者带来更好的治疗效果。这些治疗在数天到数周内见效,一些研究显示缓解率高达 78%。

However, the current healthcare system is designed to deliver long-term medication-based management, not the more episodic interventional brain medicine supported by modern evidence. Further, the system does not measure outcomes, which limits payors ability to pay for the best care possible, and clinicians lack the best clinical decision support and operational tools to enable these new forms of care at scale..

然而,当前的医疗系统旨在提供基于长期药物治疗的管理,而非现代证据支持的更偶发性的介入性脑医学。此外,该系统并不衡量结果,这限制了支付方为尽可能最佳的护理买单的能力,而临床医生也缺乏最好的临床决策支持和操作工具,以大规模实现这些新形式的护理。

Radial is addressing this problem for patients, providers, and payers by developing clinical infrastructure, reimbursement tools, and decision support that's designed around modern brain medicine. The company is building a national network of clinics that accept most major forms of insurance, including Medicare, Tricare, VA-CCN, Aetna, Cigna, United, and many Blues plans.

Radial公司正在通过开发围绕现代脑医学设计的临床基础设施、报销工具和决策支持系统,来为患者、医疗服务提供者和支付方解决这一问题。该公司正在建立一个全国性的诊所网络,接受大多数主要形式的保险,包括联邦医疗保险、Tricare、VA-CCN、安泰保险、信诺保险、联合健康保险以及许多蓝十字计划。

For patients, this means the most effective combination of therapies are available to everyone who needs them. For clinicians, this means focusing on providing that care. And, for payors, this means better outcomes and less ultimate cost for even the most complex patients..

对患者而言,这意味着每位有需要的患者都能获得最有效的治疗组合。对临床医生而言,这意味着专注于提供这种治疗。对支付方而言,这意味着更好的疗效,甚至对于最复杂的患者也能降低最终成本。

John Capecelatro, CEO and co-founder of Radial, commented, 'People who are struggling with mental health can't wait years to see if something might help through trial and error. New rapid-acting treatments work in days or weeks instead of years. We're seeing remission rates for depression of 50-60% and as high as 78% in some studies our team has co-authored.

约翰·卡佩塞拉特罗,Radial公司的首席执行官兼联合创始人评论道:“那些正在与心理健康问题作斗争的人无法等待数年,通过反复试验来看某种方法是否可能有效。新的速效治疗方法在几天或几周内起效,而不是数年。我们看到抑郁症的缓解率达到50-60%,在我们团队参与的一些研究中甚至高达78%。”

The healthcare system hasn't caught up. Radial is here to change that. When we have tools for the right clinical workflows and insurance pathways, people can access therapies that help them get better far sooner. It's a dramatic difference for individuals, for families, and for the health system that ends up carrying the cost when care drags on without results.'.

医疗系统尚未跟上。Radial 就是为了改变这一现状而来。当我们拥有适用于正确临床工作流程和保险路径的工具时,人们就能更快获得帮助他们康复的治疗。这对个人、家庭以及最终因治疗拖延而承担成本的医疗系统来说,都是一个巨大的差异。

Reva Nohria, Partner at General Catalyst, said, 'Psychiatry is undergoing a transformation, but most of that progress hasn't reached patients. The science is there, yet the infrastructure to deliver modern, brain-based treatments at scale is still missing. Radial understands both the clinical evidence and the operational complexity required to close that gap.

通用催化剂公司的合伙人雷瓦·诺里亚说:“精神病学正在经历一场变革,但大多数进展还未惠及患者。科学已经存在,但大规模提供现代化、基于大脑的治疗所需的基础设施仍然缺失。Radial 既了解临床证据,也了解弥合这一差距所需的操作复杂性。”

We believe this work can meaningfully expand access to effective mental health care.'.

我们相信这项工作可以有意义地扩大获得有效心理健康护理的机会。

Owen Muir, Chief Medical Officer at Radial, added, 'In research, we've proven that these powerful treatments work. They change lives. The hard part has always been bringing them into everyday clinical practice. Radial was built to close that gap. We're taking what we know from years of clinical research and turning it into care that any patient can access.

欧文·缪尔,Radial的首席医疗官补充道:“在研究中,我们已经证明了这些强大的治疗方法是有效的。它们改变了人们的生活。困难的部分一直是将它们引入到日常临床实践中。Radial的建立就是为了弥合这一差距。我们正在将多年来从临床研究中获得的知识转化为任何患者都可以获得的治疗。”

Radial is focused on the care patients have long deserved.'.

Radial 专注于患者长期以来应得的护理。

Radial currently operates with seven clinics in six states, supported by its proprietary software platform. This fundraising will support the company's plans to expand nationally in 2026, growing both its clinic network and technology partnerships.

Radial目前在六个州运营着七家诊所,这些诊所由其专有的软件平台提供支持。此次融资将支持该公司在2026年实现全国扩张的计划,扩大其诊所网络和技术合作伙伴关系。

About Radial

关于Radial

Radial is expanding access to the world's most advanced mental health treatments by Radial is developing clinical infrastructure, reimbursement tools, and AI-guided decision support designed around novel psychiatry treatments like neuromodulation (e.g. TMS), medication (e.g. Spravato), and other interventional therapies.

Radial 正在通过开发临床基础设施、报销工具和围绕新型精神病治疗(如神经调节(例如 TMS)、药物(例如 Spravato)和其他介入疗法)设计的 AI 辅助决策支持,来扩大获得世界上最先进心理健康治疗的机会。

Their goal is to make transformative brain medicine accessible to all. Learn more at www.meetradial.com..

他们的目标是让所有人都能获得变革性的脑科医学。更多信息请访问 www.meetradial.com。

Contact:

联系:

Media Contact:

媒体联系人:

Jacquelyn Miller

杰奎琳·米勒

‪415-745-1794

415-745-1794

406203@email4pr.com

406203@email4pr.com